APA (7th ed.) Citation

Liuhto, N., Tuominen, J., Manni, N., Hakamäki, M., Lankinen, R., Toukola, T., . . . Hellman, T. (2026). Plasma cell-free DNA measured prior to renal replacement therapy initiation is not associated with incident adverse outcomes, hospitalizations or malignancies in chronic kidney disease stage 4–5 patients. PLoS ONE, 21(7), 1. https://doi.org/10.1371/journal.pone.0353258

Chicago Style (17th ed.) Citation

Liuhto, Niilo, et al. "Plasma Cell-free DNA Measured Prior to Renal Replacement Therapy Initiation Is Not Associated with Incident Adverse Outcomes, Hospitalizations or Malignancies in Chronic Kidney Disease Stage 4–5 Patients." PLoS ONE 21, no. 7 (2026): 1. https://doi.org/10.1371/journal.pone.0353258.

MLA (9th ed.) Citation

Liuhto, Niilo, et al. "Plasma Cell-free DNA Measured Prior to Renal Replacement Therapy Initiation Is Not Associated with Incident Adverse Outcomes, Hospitalizations or Malignancies in Chronic Kidney Disease Stage 4–5 Patients." PLoS ONE, vol. 21, no. 7, 2026, p. 1, https://doi.org/10.1371/journal.pone.0353258.